Ten remarkable facts about making antibody medicines

Published on: 9 November 2020

Cancer care can’t wait

Lung cancer in the era of COVID-19

Published on: 4 March 2020

Roche Voices

In our Roche blog, find unfiltered opinions and personal stories from our employees on science, healthcare and life.

Published on: 19 November 2020

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Published on: 29 June 2020

These days, the media is full of news about diagnostic tests. But how much do you actually know? What’s the difference between an Antibody test and an Antigen test? What is a false-positive mean?

Test your knowledge on all the lingo and become an expert on diagnostics vocabulary.

Published on: 20 November 2020

Careers

Find jobs and learn more about exciting career opportunities at Roche, one of the world's leading research-based healthcare companies. Apply online...

Published on: 30 July 2020

Pharma Technical Operations delivers for patients during COVID-19

Making biologics is complicated under the best circumstances. But in the midst of a pandemic, Roche & Genentech teams are doing it faster than ever.

Published on: 30 October 2020

Finding cancer’s fingerprint

How comprehensive genomic profiling – through tissue and liquid-based approaches – is driving truly personalised cancer care.

Published on: 16 April 2020

Roche COVID-19 response

We are working together with partners in the industry, our customers, NGOs, governments and regulatory bodies to ensure we do all we can to help contain the novel coronavirus.

Published on: 30 April 2020

COVID-19: How antibody tests help to detect those already infected with SARS-CoV-2

SARS CoV-2 infections often go without symptoms. Antibody tests can identify individuals who have been exposed to the virus. Learn how this works.

Published on: 28 April 2020

COVID-19 and the mysterious world of antibodies

Timothy Tellinghuisen, Head of Virology Discovery, explains why understanding antibodies could hold the key in tackling COVID-19 and other pandemics.